Glutathione provides a source of cysteine essential for intracellular multiplication of Francisella tularensis

PLoS Pathogens

Volumn 5, Issue 1, 2009, Pages

  Alkhuder, Khaled ^a,b   Meibom, Karin L ^a,b   Dubail, Iharilalao ^a,b   Dupuis, Marion ^a,b   Charbit, Alain ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE; DIPEPTIDE; GAMMA GLUTAMYLCYSTEINE; GAMMA-GLUTAMYLCYSTEINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL REPRODUCTION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BACTERIUM MUTANT; CELL INVASION; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; FRANCISELLA TULARENSIS; GENETIC CODE; GENETIC COMPLEMENTATION; HOST PATHOGEN INTERACTION; MACROPHAGE; MOUSE; NONHUMAN; SCREENING; TRANSPOSON; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; CYTOLOGY; CYTOSOL; GENETICS; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGY; MUTATION; PATHOGENICITY; PLASMID; VIRULENCE;

BACTERIA (MICROORGANISMS); FRANCISELLA TULARENSIS; MUS;

ANIMALS; CELL LINE; CYSTEINE; CYTOSOL; DIPEPTIDES; ESCHERICHIA COLI; FEMALE; FRANCISELLA TULARENSIS; GAMMA-GLUTAMYLTRANSFERASE; GENES, BACTERIAL; GENETIC COMPLEMENTATION TEST; GLUTATHIONE; MACROPHAGES; MICE; MICE, INBRED BALB C; MICROBIAL VIABILITY; MUTATION; PLASMIDS; VIRULENCE;

EID: 59249084463     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000284     Document Type: Article

References (66)

1. Titball RW, Sjostedt A, Pavelka MS Jr, Nano FE (2007) Biosafety and selectable markers. Ann N Y Acad Sci 1105: 405-417.
2. Ellis J, Oyston PC, Green M, Titball RW (2002) Tularemia. Clin Microbiol Rev 15: 631-646.
3. Sjostedt A (2007) Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations. Ann N Y Acad Sci 1105: 1-29.
4. Barker JR, Klose KE (2007) Molecular and genetic basis of pathogenesis in Francisella tularensis. Ann N Y Acad Sci 1105: 138-159.
5. Brotcke A, Weiss DS, Kim CC, Chain P, Malfatti S, et al. (2006) Identification of MglA-regulated genes reveals novel virulence factors in Francisella tularensis. Infect Immun 74: 6642-6655.
6. Golovliov I, Baranov V, Krocova Z, Kovarova H, Sjostedt A (2003) An attenuated strain of the facultative intracellular bacterium Francisella tularensis can escape the phagosome of monocytic cells. Infect Immun 71: 5940-5950.
7. Gray CG, Cowley SC, Cheung KK, Nano FE (2002) The identification of five genetic loci of Francisella novicida associated with intracellular growth. FEMS Microbiol Lett 215: 53-56.
8. Lauriano CM, Barker JR, Yoon SS, Nano FE, Arulanandam BP, et al. (2004) MglA regulates transcription of virulence factors necessary for Francisella tularensis intraamoebae and intramacrophage survival. Proc Natl Acad Sci U S A 101: 4246-4249.
9. Nano FE, Zhang N, Cowley SC, Klose KE, Cheung KK, et al. (2004) A Francisella tularensis pathogenicity island required for intramacrophage growth. J Bacteriol 186: 6430-6436.
10. Nano FE, Schmerk C (2007) The Francisella pathogenicity island. Ann N Y Acad Sci 1105: 122-137.
11. Santic M, Molmeret M, Barker JR, Klose KE, Dekanic A, et al. (2007) A Francisella tularensis pathogenicity island protein essential for bacterial proliferation within the host cell cytosol. Cell Microbiol 9: 2391-2403.
12. Mohapatra NP, Soni S, Bell BL, Warren R, Ernst RK, et al. (2007) Identification of an orphan response regulator required for the virulence of Francisella spp. and transcription of pathogenicity island genes. Infect Immun 75: 3305-3314.
13. Charity JC, Costante-Hamm MM, Balon EL, Boyd DH, Rubin EJ, et al. (2007) Twin RNA polymerase-associated proteins control virulence gene expression in Francisella tularensis. PLoS Pathog 3: e84. doi:10.1371/journal.ppat. 0030084.
14. Sebastian S, Dillon ST, Lynch JG, Blalock LT, Balon E, et al. (2007) A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity. Infect Immun 75: 2591-2602.
15. Wang X, Ribeiro AA, Guan Z, Abraham SN, Raetz CR (2007) Attenuated virulence of a Francisella mutant lacking the lipid A 4′-phosphatase. Proc Natl Acad Sci U S A 104: 4136-4141.
16. Raynaud C, Meibom KL, Lety MA, Dubail I, Candela T, et al. (2007) Role of the wbt locus of Francisella tularensis in lipopolysaccharide O-antigen biogenesis and pathogenicity. Infect Immun 75: 536-541.
17. Thomas RM, Titball RW, Oyston PC, Griffin K, Waters E, et al. (2007) The immunologically distinct O antigens from Francisella tularensis subspecies tularensis and Francisella novicida are both virulence determinants and protective antigens. Infect Immun 75: 371-378.
18. Tempel R, Lai XH, Crosa L, Kozlowicz B, Heffron F (2006) Attenuated Francisella novicida transposon mutants protect mice against wild-type challenge. Infect Immun 74: 5095-5105.
19. Su J, Yang J, Zhao D, Kawula TH, Banas JA, et al. (2007) Genome-wide identification of Francisella tularensis virulence determinants. Infect Immun 75: 3089-3101.
20. Weiss DS, Brotcke A, Henry T, Margolis JJ, Chan K, et al. (2007) In vivo negative selection screen identifies genes required for Francisella virulence. Proc Natl Acad Sci U S A 104: 6037-6042.
21. Maier TM, Casey MS, Becker RH, Dorsey CW, Glass EM, et al. (2007) Identification of Francisella tularensis Himar1-based transposon mutants defective for replication in macrophages. Infect Immun 75: 5376-5389.
22. Camilli A, Paynton C, Portnoy D (1989) Intracellular methicillin selection of Listeria monocytogenes mutants unable to replicate in a macrophage cell line. Proc Natl Acad Sci U S A 86: 5522-5526.
23. Griffith OW (1999) Biologic and pharmacologic regulation of mammalian glutathione synthesis. Free Radic Biol Med 27: 922-935.
24. Kaplowitz N, Aw TY, Ookhtens M (1985) The regulation of hepatic glutathione. Annu Rev Pharmacol Toxicol 25: 715-744.
25. Orlowski M, Meister A (1970) The gamma-glutamyl cycle: a possible transport system for amino acids. Proc Natl Acad Sci U S A 67: 1248-1255.
26. Chamberlain RE (1965) Evaluation of Live Tularemia Vaccine Prepared in a Chemically Defined Medium. Appl Microbiol 13: 232-235.
27. Larsson P, Oyston PC, Chain P, Chu MC, Duffield M, et al. (2005) The complete genome sequence of Francisella tularensis, the causative agent of tularemia. Nat Genet 37: 153-159.
28. Baker C, Hollis D, Thornsberry C (1985) Antimicrobial susceptibility testing of Francisella tularensis with a modified Mueller-Hinton broth. J Clin Microbol 22: 212-215.
29. Ekinci B, Coban AY, Birinci A, Durupinar B, Erturk M (2002) In vitro effects of cefotaxime and ceftriaxone on Salmonella typhi within human monocyte-derived macrophages. Clin Microbiol Infect 8: 810-813.
30. Maier TM, Pechous R, Casey M, Zahrt TC, Frank DW (2006) In vivo Himar1-based transposon mutagenesis of Francisella tularensis. Appl Environ Microbiol 72: 1878-1885.
31. Roth Z (1961) [A graphic probit method for the calculation of LD50 and relative toxicity.] Cesk Fysiol 10: 408-422.
32. Tarnvik A (1989) Nature of protective immunity to Francisella tularensis. Rev Infect Dis 11: 440-451.
33. Sorokin VM, Pavlovich NV, Prozorova LA (1996) Francisella tularensis resistance to bactericidal action of normal human serum. FEMS Immunol Med Microbiol 13: 249-252.
34. Thomas RM, Titball RW, Oyston PC, Griffin K, Waters E, et al. (2007) The immunologically distinct O antigens from Francisella tularensis subspecies tularensis and Francisella novicida are both virulence determinants and protective antigens. Infect Immun 75: 371-378.
35. Clay CD, Soni S, Gunn JS, Schlesinger LS (2008) Evasion of complement-mediated lysis and complement C3 deposition are regulated by Francisella tularensis lipopolysaccharide O antigen. J Immunol 181: 5568-5578.
36. Candela T, Fouet A (2006) Poly-gamma-glutamate in bacteria. Mol Microbiol 60: 1091-1098.
37. Sjostedt A (2004) Gram-negative aerobic cocci. Family XVII. Francisellaceae. In: Brenner DJ, ed. Bergey's Manual of Systematic Bacteriology. New York: Springer. pp 200-210.
38. Suzuki H, Hashimoto W, Kumagai H (1993) Escherichia coli K-12 can utilize an exogenous gamma-glutamyl peptide as an amino acid source, for which gamma-glutamyltranspeptidase is essential. J Bacteriol 175: 6038-6040.
39. Suzuki H, Kamatani S, Kim ES, Kumagai H (2001) Aminopeptidases A, B, and N and dipeptidase D are the four cysteinylglycinases of Escherichia coli K-12. J Bacteriol 183: 1489-1490.
40. Meister A, Anderson ME (1983) Glutathione. Annu Rev Biochem 52: 711-760.
41. Test S, Weiss S (1984) Quantitative and temporal characterization of the extracellular H2O2 pool generated by human neutrophils. J Biol Chem 259: 399-405.
42. Ahmed N, Kansara M, Berridge MV (1997) Acute regulation of glucose transport in a monocyte-macrophage cell line: Glut-3 affinity for glucose is enhanced during the respiratory burst. Biochem J 327(Pt 2): 369-375.
43. Brune B, Gotz C, Messmer U, Sandau K, Hirvonen M, et al. (1997) Superoxide formation and macrophage resistance to nitric oxide-mediated apoptosis. J Biol Chem 272: 7253-7258.
44. Winterbourn C, Hampton M, Livesey J, Kettle A (2006) Modeling the reactions of superoxide and myeloperoxidase in the neutrophil phagosome: implications for microbial killing. J Biol Chem 281: 39860-39869.
45. Qin A, Mann BJ (2006) Identification of transposon insertion mutants of Francisella tularensis tularensis strain Schu S4 deficient in intracellular replication in the hepatic cell line HepG2. BMC Microbiol 6: 69.
46. Sandstrom G, Lofgren S, Tarnvik A (1988) A capsule-deficient mutant of Francisella tularensis LVS exhibits enhanced sensitivity to killing by serum but diminished sensitivity to killing by polymorphonuclear leukocytes. Infect Immun 56: 1194-1202.
47. Hanigan MH, Ricketts WA (1993) Extracellular glutathione is a source of cysteine for cells that express gamma-glutamyl transpeptidase. Biochemistry 32: 6302-6306.
48. Lieberman MW, Wiseman AL, Shi ZZ, Carter BZ, Barrios R, et al. (1996) Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidasedeficient mice. Proc Natl Acad Sci U S A 93: 7923-7926.
49. Mehdi K, Penninckx MJ (1997) An important role for glutathione and gamma-glutamyltranspeptidase in the supply of growth requirements during nitrogen starvation of the yeast Saccharomyces cerevisiae. Microbiology 143: 1885-1889.
50. Minami H, Suzuki H, Kumagai H (2004) Gamma-glutamyltranspeptidase, but not YwrD, is important in utilization of extracellular blutathione as a sulfur source in Bacillus subtilis. J Bacteriol 186: 1213-1214.
51. Sherrill C, Fahey RC (1998) Import and metabolism of glutathione by Streptococcus mutans. J Bacteriol 180: 1454-1459.
52. McGovern KJ, Blanchard TG, Gutierrez JA, Czinn SJ, Krakowka S, et al. (2001) gamma-Glutamyltransferase is a Helicobacter pylori virulence factor but is not essential for colonization. Infect Immun 69: 4168-4173.
53. Schmees C, Prinz C, Treptau T, Rad R, Hengst L, et al. (2007) Inhibition of T-cell proliferation by Helicobacter pylori gamma-glutamyl transpeptidase. Gastroenterology 132: 1820-1833.
54. Chevalier C, Thiberge JM, Ferrero RL, Labigne A (1999) Essential role of Helicobacter pylori gamma-glutamyltranspeptidase for the colonization of the gastric mucosa of mice. Mol Microbiol 31: 1359-1372.
55. Shibayama K, Kamachi K, Nagata N, Yagi T, Nada T, et al. (2003) A novel apoptosis-inducing protein from Helicobacter pylori. Mol Microbiol 47: 443-451.
56. Shibayama K, Wachino J, Arakawa Y, Saidijam M, Rutherford NG, et al. (2007) Metabolism of glutamine and glutathione via gamma-glutamyltranspeptidase and glutamate transport in Helicobacter pylori: possible significance in the pathophysiology of the organism. Mol Microbiol 64: 396-406.
57. Wu G, Fang Y, Yang S, Lupton J, Turner N (2004) Glutathione metabolism and its implications for health. J Nutr 134: 489-492.
58. Franco R, Schoneveld OJ, Pappa A, Panayiotidis MI (2007) The central role of glutathione in the pathophysiology of human diseases. Arch Physiol Biochem 113: 234-258.
59. Eriksson S, Lucchini S, Thompson A, Rhen M, Hinton J (2003) Unravelling the biology of macrophage infection by gene expression profiling of intracellular Salmonella enterica. Mol Microbiol 47: 103-118.
60. Chatterjee S, Hossain H, Otten S, Kuenne C, Kuchmina K, et al. (2006) Intracellular gene expression profile of Listeria monocytogenes. Infect Immun 74: 1323-1338.
61. Joseph B, Przybilla K, Stuhler C, Schauer K, Slaghuis J, et al. (2006) Identification of Listeria monocytogenes genes contributing to intracellular replication by expression profiling and mutant screening. J Bacteriol 188: 556-568.
62. Fontan P, Aris V, Ghanny S, Soteropoulos P, Smith I (2008) Global transcriptional profile of Mycobacterium tuberculosis during THP-1 human macrophage infection. Infect Immun 76: 717-725.
63. Chico-Calero I, Suarez M, Gonzalez-Zorn B, Scortti M, Slaghuis J, et al. (2002) Hpt, a bacterial homolog of the microsomal glucose- 6-phosphate translocase, mediates rapid intracellular proliferation in Listeria. Proc Natl Acad Sci U S A 99: 431-436.
64. Scortti M, Lacharme-Lora L, Wagner M, Chico-Calero I, Losito P, et al. (2006) Coexpression of virulence and fosfomycin susceptibility in Listeria: molecular basis of an antimicrobial in vitro-in vivo paradox. Nat Med 12: 515-517.
65. Meibom KL, Dubail I, Dupuis M, Barel M, Lenco J, et al. (2008) The heatshock protein ClpB of Francisella tularensis is involved in stress tolerance and is required for multiplication in target organs of infected mice. Mol Microbiol 67: 1384-1401.
66. Kuoppa K, Forsberg A, Norqvist A (2001) Construction of a reporter plasmid for screening in vivo promoter activity in Francisella tularensis. FEMS Microbiol Lett 205: 77-81.